Nasdaq
$22.95▼ 0.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $744.4MShares out 32.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 5d agoAfter-hours26.10.20 05:058-KKey event#●●●#●●●
COLLEGIUM PHARMACEUTICAL, INCBullish
Collegium Pharmaceutical has reached a settlement with Grünenthal to resolve all disputes, including the Nucynta patent litigation, for a payment of $17 million. Under the agreement, the existing license agreement was terminated effective October 15, 2026, discharging the company from all future royalty obligations and resulting in the assignment of certain patents to the company.…more
$22.95-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8After-hours26.10.09 07:27SCHEDULE 13G/AOwnership
COLLEGIUM PHARMACEUTICAL, INC
Integrated Core Strategies (US) LLC, Millennium Management LLC, and related entities have entered into a joint filing agreement for the Schedule 13G regarding their beneficial ownership of Collegium Pharmaceutical, Inc. common stock. This agreement, dated October 7, 2026, facilitates the joint reporting of equity holdings in accordance with Rule 13d-1(k) of the Securities Exchange Act.…more
$22.95-0.09%vs prev closeView filingShare - 9.30Regular26.10.01 04:52144Ownership
COLLEGIUM PHARMACEUTICAL, INC
Scott Dreyer of Collegium Pharmaceutical has filed an SEC Form 144 to report the proposed sale of company shares. This filing formally declares the insider's intention to sell their holdings in the open market.…more
$22.95-0.09%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:00#●●●#●●●
Collegium Pharmaceutical to Report Q3 2026 Financial Results on November 5…more
Collegium Pharmaceutical announced that it will release its financial results for the third quarter of 2026 before the market opens on November 5, 2026. A live conference call and webcast will follow the announcement to discuss the company's performance.…more
$22.95-0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 4d agoPre-market26.10.21 21:00
●●●●●●●● ●●●●● ●●●●●●
Collegium Pharmaceutical announced it will present clinical and real-world research findings regarding its ADHD treatments, AZSTARYS and JORNAY PM, at two upcoming medical congresses. These presentations focus on academic data and patient outcomes, representing standard scientific activity rather than immediate financial catalysts.…more
$22.95-0.09%vs prev close - 5d agoAfter-hours26.10.20 05:30
●●●●●●●● ●●●●● ●●●●●●
Collegium Pharmaceutical has reached a settlement with Grünenthal to resolve patent litigation for a payment of $17 million. This agreement terminates the license and eliminates future royalty obligations, resolving the legal dispute.…more
$22.95-0.09%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report